Sharon C. Murray

Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies

David Olmos, Douglas S. Barker, Rohini Sharma et al. · Clinical Cancer Research · 2011 · 168 citations · Full text

Medicine, Oncology, Pharmacology +16

Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial

Bruce L. Zuraw, William R. Lumry, Douglas Johnston et al. · Journal of Allergy and Clinical Immunology · 2020 · 163 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Next Generation Pharmaceutical Impactor (A New Impactor for Pharmaceutical Inhaler Testing). Part II: Archival Calibration

Virgil A. Marple, Bernard A. Olson, Kumaragovindham Santhanakrishnan et al. · Journal of Aerosol Medicine · 2003 · 146 citations

Pharmacy, Manufacturing Engineering, Pharmaceutics +17

Micronutrients and the Risk of Colorectal Adenomas

Marilyn Tseng, Sharon C. Murray, Lawrence L. Kupper et al. · American Journal of Epidemiology · 1996 · 131 citations · Full text

Public Health, Nutrition, Nutritional Sciences +15

Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study

Peadar N. Kirke, James L. Mills, Anne M. Molloy et al. · BMJ · 2004 · 126 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17